<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    OrthoPediatrics Corp.

    OrthoPediatrics Corp.

    OrthoPediatrics currently markets greater than 30 surgical systems that serve thre...

    OrthoPediatrics currently markets greater than ...

    Filing Type:    PU
    electroCore, Inc.

    electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated t...

    electroCore, Inc. is a commercial stage bioelec...

    Filing Type:    PU
    Sophiris Bio, Inc.

    Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin ...

    Sophiris Bio Inc. is a late-stage biopharmaceut...

    Filing Type:    PU
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    NuVasive, Inc.

    NuVasive, Inc.

    NuVasive is a world leader in minimally invasive, procedurally integrated spine so...

    NuVasive is a world leader in minimally invasiv...

    Filing Type:    PU
    Abeona Therapeutics, Inc.

    Abeona Therapeutics, Inc.

    Abeona Therapeutics is focused on developing and delivering gene therapy products ...

    Abeona Therapeutics is focused on developing an...

    Filing Type:    PU
    Beyond Air, Inc.

    Beyond Air, Inc.

    Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company d...

    Beyond Air Inc. is a clinical-stage medical dev...

    Filing Type:    PU
    ReWalk Robotics Ltd.

    ReWalk Robotics Ltd.

    ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company. We design,...

    ReWalk Robotics (Nasdaq: RWLK) is an innovative...

    Filing Type:    PU
    Orthofix Medical Inc.

    Orthofix Medical Inc.

    ​​Orthofix Medical Inc. is a diversified, global medical device company focuse...

    ​​Orthofix Medical Inc. is a diversified, g...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.